Safety and Efficacy Study of Lucanthone When Used in Combination With Temozolomide(TMZ) and Radiation to Treat Glioblastoma Multiforme(GBM)
Clinical trial NCT01587144 · TERMINATED
Trial details
- NCT number
- NCT01587144
- Sponsor
- Spectrum Pharmaceuticals, Inc
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-19
- Primary completion
- 2013-04-15
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.